These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19404004)

  • 1. [Application of NFkappaB inhibitor for arthritis].
    Tomita T; Kunugiza Y; Nomura K; Morimoto D; Kuroda S; Yoshikawa H
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):71-6. PubMed ID: 19404004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis.
    Tomita T; Takano H; Tomita N; Morishita R; Kaneko M; Shi K; Takahi K; Nakase T; Kaneda Y; Yoshikawa H; Ochi T
    Rheumatology (Oxford); 2000 Jul; 39(7):749-57. PubMed ID: 10908694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy.
    Tomita T; Takeuchi E; Tomita N; Morishita R; Kaneko M; Yamamoto K; Nakase T; Seki H; Kato K; Kaneda Y; Ochi T
    Arthritis Rheum; 1999 Dec; 42(12):2532-42. PubMed ID: 10615998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-oxidant gene therapy by NF kappa B decoy oligodeoxynucleotide.
    Nakagami H; Tomita N; Kaneda Y; Ogihara T; Morishita R
    Curr Pharm Biotechnol; 2006 Apr; 7(2):95-100. PubMed ID: 16724943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts.
    Shimizu H; Nakagami H; Tsukamoto I; Morita S; Kunugiza Y; Tomita T; Yoshikawa H; Kaneda Y; Ogihara T; Morishita R
    Gene Ther; 2006 Jun; 13(12):933-41. PubMed ID: 16511526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for arthritis.
    Tomita T; Hashimoto H; Yoshikawa H
    Curr Drug Targets; 2003 Nov; 4(8):609-12. PubMed ID: 14577650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFkappaB and ets using chimeric decoy oligonucleotides in a rabbit model.
    Miyake T; Aoki M; Nakashima H; Kawasaki T; Oishi M; Kataoka K; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    Gene Ther; 2006 Apr; 13(8):695-704. PubMed ID: 16397509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model.
    Yamasaki K; Asai T; Shimizu M; Aoki M; Hashiya N; Sakonjo H; Makino H; Kaneda Y; Ogihara T; Morishita R
    Gene Ther; 2003 Feb; 10(4):356-64. PubMed ID: 12595894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F decoy oligodeoxynucleotide ameliorates cartilage invasion by infiltrating synovium derived from rheumatoid arthritis.
    Tomita T; Kunugiza Y; Tomita N; Takano H; Morishita R; Kaneda Y; Yoshikawa H
    Int J Mol Med; 2006 Aug; 18(2):257-65. PubMed ID: 16820932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of decoy oligodeoxynucleotides-based approach to renal diseases.
    Tomita N; Azuma H; Kaneda Y; Ogihara T; Morishita R
    Curr Drug Targets; 2004 Nov; 5(8):717-33. PubMed ID: 15578952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of TNF-alpha, induced cytokine and adhesion molecule. Expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB.
    Tomita N; Morishita R; Tomita S; Kaneda Y; Higaki J; Ogihara T; Horiuchi M
    Exp Nephrol; 2001; 9(3):181-90. PubMed ID: 11340302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model.
    Uemura T; Tsujii M; Akeda K; Iino T; Satonaka H; Hasegawa M; Sudo A
    J Gene Med; 2012 Nov; 14(11):623-31. PubMed ID: 23080520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of collagen-induced arthritis using antigen-loaded dendritic cells modified with NF-κB decoy oligodeoxynucleotides.
    Jiang H; Hu H; Zhang Y; Yue P; Ning L; Zhou Y; Shi P; Yuan R
    Drug Des Devel Ther; 2017; 11():2997-3007. PubMed ID: 29075103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.
    Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T
    Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats.
    Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF
    Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oligonucleotide-based therapy as a potential new pharmacotherapy].
    Morishita R
    Nihon Yakurigaku Zasshi; 2000 Mar; 115(3):123-30. PubMed ID: 10876797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease.
    Morishita R; Higaki J; Tomita N; Ogihara T
    Circ Res; 1998 Jun; 82(10):1023-8. PubMed ID: 9622154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential therapeutic applications of decoy oligonucleotides.
    Tomita N; Morishita R; Tomita T; Ogihara T
    Curr Opin Mol Ther; 2002 Apr; 4(2):166-70. PubMed ID: 12044038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel decoy oligonucleotides: advantages of circular dumb-bell decoy.
    Tomita N; Tomita T; Yuyama K; Tougan T; Tajima T; Ogihara T; Morishita R
    Curr Opin Mol Ther; 2003 Apr; 5(2):107-12. PubMed ID: 12772498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfection of NFkappaB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts.
    Azuma H; Tomita N; Kaneda Y; Koike H; Ogihara T; Katsuoka Y; Morishita R
    Gene Ther; 2003 Mar; 10(5):415-25. PubMed ID: 12601396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.